Leiden Jeffrey M

Executive Chairman | CEO &President | Director

2 companies

Insider Signal Score

Average

Trades Analyzed

12M Win Rate

14.3%

Avg 3M Return

-2.8%

Avg 12M Return

-11.7%

Leiden Jeffrey M is an Executive Chairman at VERTEX PHARMACEUTICALS INC / MA with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 63 sells.

Estimated insider holdings value: $11.9M based on current market prices.

Holdings by Company

VRTXDec 4, 2025

Current Shares24.0K

Value$10.80M

Net Activity-1,221,678

Bought: 0Sold: 1.22M

DGXMay 29, 2018

Current Shares6.0K

Value$1.14M

Net Activity-9,589

Bought: 0Sold: 9.6K

Transaction History

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 25, 2022	VRTX Vertex Pharmaceuticals Inc / Ma	Executive Chairman	Sale+OE	132,079	$281.38	$37,164,480.57	-32.3%	+9.5%	+26.2%
Apr 13, 2022	VRTX Vertex Pharmaceuticals Inc / Ma	Executive Chairman	Sell	15,789	$289.04	$4,563,652.56	-17.6%	-0.3%	+14.6%
Jun 30, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	Executive Chairman	Sell	32,792	$286.15	$9,383,303.77	-28.3%	-	-
May 12, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	Executive Chairman	Sale+OE	94,370	$283.47	$26,751,440.10	-8.9%	-	-
May 7, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	Executive Chairman	Sale+OE	94,369	$269.78	$25,459,013.12	-17.1%	-	-
May 5, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	Executive Chairman	Sale+OE	94,372	$269.94	$25,475,036.61	-10.4%	-	-
Feb 25, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	CEO &President	Sell	10,550	$233.46	$2,463,045.63	-1.3%	-	-
Feb 18, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	CEO &President	Sell	11,685	$243.52	$2,845,518.24	-2.0%	-	-
Feb 11, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	CEO &President	Sell	47,523	$246.09	$11,694,933.45	-4.9%	-	-
Nov 19, 2019	VRTX Vertex Pharmaceuticals Inc / Ma	CEO &President	Sale+OE	96,534	$210.91	$20,360,051.70	-21.0%	-	-

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC